TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals
Curated by ChEMBL
Affinium Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals
Curated by ChEMBL
Affinium Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair